Noxopharm Ltd has released a press release.
Noxopharm Investigating Potential COVID-19 Treatment
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from Noxopharm
- Veyonda Awarded First Allowed Patent Application
- LuPIN Prostate Cancer Trial Fully Recruited
- Half Year Accounts and Chairman Letter
- FDA grants IND approval to Veyonda
- Noxopharm Alliance With GenesisCare
Later from Noxopharm
- Approval to be sought for COVID-19 Clinical Study in U.S.
- Pipeline Expands With Potential New Brain Cancer Treatment
- Abscopal Responses Achieved in Prostate Cancer
- Noxopharm March 2020 Quarterly Report & Appendix 4C
- $7.9 Million Fully Underwritten Entitlement Offer Announced
Follow Noxopharm into a list and get an email when it puts out news.
Follow Noxopharm